Our Approach

Ardelyx develops:

  • Drugs that target proteins found in the gut whose activities affect the entire body
  • Drugs that are not absorbed, enabling them to achieve systemic efficacy while avoiding systemic toxicity and side effects

What we do

Targeted Therapeutic Areas

Ardelyx has established a unique approach to drug development with programs targeting gut transporters, receptors, and enzymes

Therapeutic Areas

Products

Program Indication Pre-Clin.Phase 1Phase 2Phase 3
RDX5791 IBS-C * * * * 
RDX5791 Hypertension * * * * 
RDX008 Hypertension * * * * 
RDX002 CKD * * * * 
RDX009 Diabetes * * * *